Literature DB >> 361410

Further experiences with the specific red cell adherence test (SRCA) in bladder cancer. a histological and cytological study.

G Jakse, F Hofstädter.   

Abstract

The red cell adherence test allows the disclosure of the blood group antigens incorporated on the surface of the urothelium. In the course of dedifferentiation the urothelium will lose its antigenicity. We applied this test on superfical bladder tumours (T1), carcinoma in situ and cytological specimens and observed a close correlation between the test results and the course of the disease, e.g. if the test was positive the recurrent tumour would be superficial and vice versa. As a rule the negative results revealed atypical hyperplasia and carcinoma in situ as areas of potentially malignant and invasive tumours. With the application of the red cell adherence test to cytological preparations we can probably improve the accuracy of the cytological examination in cases of transitional cancer of low malignancy.

Entities:  

Mesh:

Year:  1978        PMID: 361410     DOI: 10.1159/000473993

Source DB:  PubMed          Journal:  Eur Urol        ISSN: 0302-2838            Impact factor:   20.096


  3 in total

1.  Blood group antigens and bladder cancer.

Authors:  M C Bishop
Journal:  Br Med J (Clin Res Ed)       Date:  1982-05-15

2.  ABH antigenicity of in situ carcinoma of the urinary bladder during intracavity treatment with doxorubicin hydrochloride.

Authors:  G Jakse; F Hofstädter
Journal:  Urol Res       Date:  1981

3.  Mechanisms of action of intravesical treatment. Effect on the ABH surface antigens of urothelial cells.

Authors:  G Jakse; F Hofstädter
Journal:  Cancer Chemother Pharmacol       Date:  1983       Impact factor: 3.333

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.